10/15/2026

Janusmed sex and gender

Janusmed sex and gender – Fluticasone – nasal spray

Janusmed Sex and Gender is a knowledge database providing information on sex and gender aspects of drug treatment. The knowledge database is primarily intended to be used by physicians and healthcare professionals. The texts are general and should not be considered as treatment guidelines. The individual patient’s physician is responsible for the patient’s drug treatment.

Back to index
B B
B B

Fluticasone – nasal spray

Fluticasone – nasal spray

Class : B

  1. Rosenblut A, Bardin PG, Muller B, Faris MA, Wu WW, Caldwell MF et al. Long-term safety of fluticasone furoate nasal spray in adults and adolescents with perennial allergic rhinitis. Allergy. 2007;62:1071-7.
  2. Allen A, Down G, Newland A, Reynard K, Rousell V, Salmon E et al. Absolute bioavailability of intranasal fluticasone furoate in healthy subjects. Clin Ther. 2007;29:1415-20.
  3. Food and Drug Administration (FDA). Clinical Pharmacology and Biopharmaceutics Review - Flonase (fluticasone). Drugs@FDA [www]. [updated 1997-10-31, cited 2026-03-30].
  4. Xhance (fluticasone). DailyMed [www]. US National Library of Medicine. [updated 2026-01-12, cited 2026-03-30].
  5. Statistikdatabas för läkemedel. Stockholm: Socialstyrelsen. 2025 [cited 2026-03-20.]